《港樓》啟德DOUBLE COAST I加推15伙 當中11伙價單發售折實入場462.7萬起
會德豐地產與恆地(00012.HK)、中海外(00688.HK)及新世界發展(00017.HK)合作發展、位於啟德的現樓新盤DOUBLE COAST I上載全新銷售安排。會德豐地產副主席兼常務董事黃光耀表示,加推15伙全新單位,料勢將吸引一眾專才及投資客。
最新銷售安排涉及價單發售單位共11伙,包括5個開放式及6個一房(開廚)單位,實用面積由265至327平方呎,折實售價由462.7萬至553.3萬元,折實呎價由16,183至17,634元,平均折實呎價為17,043元。至於招標發售單位共4伙,包括兩房連儲物室(開廚)單位,實用面積由462至477平方呎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.